Rapid Micro Biosystems Raises $81M to Continue Global Expansion of Automated Pharmaceutical QC Platform to Improve Data Integrity and Safety in Biologics, Vaccines, and Cell & Gene Therapy Manufacturing
LOWELL, Mass., March 16 (Korea Bizwire) — Rapid Micro Biosystems, Inc., the leading provider of data integrity and automation technology for microbial detection in biopharmaceutical manufacturing, today announced the completion of an $81 million equity financing. The funding round was led by new investor D1 Capital Partners, along with funds and accounts managed by BlackRock, [...]